 Innate Pharma SA NASDAQ: IPHA stock is trading at a 52-week high as its partner AstraZeneca Plc NASDAQ: AZN presented results from the COAST Phase 2 trial during the European Society for Medical Oncology ESMO21 Congress 2021. The trial included patients with unresectable, Stage 3 non-small cell lung cancer NSCLC who had not progressed after concurrent chemoradiation therapy CRT. 